MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer -- COMPAMED Trade Fair

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

09/29/2017

Image: different expression of the biomarker (EDB-FN) and probe binding (ZD2) in slow-growing ER-positive cancer; Copyright: Case Western Reserve University